Q1 FY27 results: revenue up 34%, profit up over 5x; sets dividend record date

Corporate Actions View source PDF Explain this filing

MOREPENLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+20.5%Reaction day

₹57.40

prior close

₹69.18

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.4%+20.1% vs market

Pharmaceuticals peers, median of 165sector-0.0%+20.6% vs sector

On the reaction day the stock moved 20.1 pts more than Nifty Microcap 250 and 20.6 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+20.5+0.4+20.1-0.0+20.6

Next day

+33.6+1.7+31.9+0.0+33.6

+38.6+2.1+36.5+0.2+38.4

+39.4+2.1+37.3+0.4+39.0

+39.5+2.1+37.5+0.6+38.9

+33.8+1.9+31.9+0.8+33.0

+41.6+2.4+39.2+0.4+41.3

15d

+63.4+3.0+60.4+0.5+63.0

+97.9+3.7+94.2+1.0+96.9

+136.4+1.6+134.9+2.0+134.5

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Morepen Labs Q1 FY27 (June 2026): consolidated revenue Rs. 57,013 lakhs, up 34% YoY. Net profit Rs. 5,640 lakhs, up over 5x YoY from Rs. 1,075 lakhs. EPS Rs. 1.03 vs Rs. 0.20. Standalone revenue Rs. 54,104 lakhs, profit Rs. 5,400 lakhs. Board set Sept 19, 2026 as record date for FY26 final dividend. Also approved hive-off of Medical Devices business to subsidiary Morepen Medipath and re-appointment of CMD Sushil Suri for 3 more years.

Likely market impact

Strong Q1 with profit up 5x on 34% revenue growth, indicating margin expansion. Dividend record date set. AGM items include Medical Devices hive-off and CMD re-appointment.